ADC Therapeutics Appoints Dr. Chris Martin as Chief Executive Officer

ADC Therapeutics Sarl, the oncology research and development company focused on Antibody Drug Conjugates – ADCs – targeting major cancers, today announced the appointment of Dr. Chris Martin as its Chief Executive Officer.

Read the full press release